Nanobac Pharmaceuticals, Incorporated (NNBP)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 21, 2026
Nanobac Pharmaceuticals Market Cap
Nanobac Pharmaceuticals has a market cap or net worth of $250 as of October 30, 2026. It is the 52,717th most valuable company in the world and the 8,688th biggest in the United States.
Market Cap
250.00
Enterprise Value
n/a
Revenue
17.62K
Global Rank
Country Rank
#8,688 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 16, 2003, Nanobac Pharmaceuticals's market cap has decreased from 18.83M to 250.00, a decrease of -100.00%. That is a compound annual growth rate of -38.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 250.00 | - |
| Dec 31, 2025 | 250.00 | - |
| Dec 23, 2024 | 250.00 | - |
| Dec 21, 2023 | 250.00 | - |
| Dec 16, 2022 | 250.00 | -99.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tengion | 402.00 |
| PharmaRoth Labs | 391.00 |
| Nabriva Therapeutics | 323.00 |
| Predictive Technology Group | 317.00 |
| Spencer Pharmaceutical | 271.00 |
| Sirona Biochem | 266.00 |
| NanoLogix | 163.00 |
| Kiromic BioPharma | 157.00 |